Showing results (281-290 of 1,523) with videos related to

Sort By:
Pageof 153
CPT: Pharmacometrics & Systems Pharmacology|May 12, 2023
Physiologically based pharmacokinetic modeling of levetiracetam to predict the exposure in hepatic and renal impairment and elderly populationsChaozhuang Shen, Wenxin Shao, Wenhui Wang, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 15, 2023
Disease progression joint model predicts time to type 1 diabetes onset: Optimizing future type 1 diabetes prevention studiesJuan Francisco Morales, Rhoda Muse, Jagdeep T Podichetty, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 12, 2023
Model-informed pediatric dose selection of marzeptacog alfa (activated): An exposure matching strategyAlan Faraj, Rob C van Wijk, Linda Neuman, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 7, 2023
Biased computation of probability of target attainment for antimicrobial drugsPierre-Louis Toutain, Peggy Gandia, Ludovic Pelligand, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 18, 2025
Toward a Quantitative Understanding of Aficamten Clinical Pharmacology: Population Pharmacokinetic ModelingDonghong Xu, Hanbin Li, Stephen B Heitner, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 11, 2025
A Systematic Comparative Analysis of Tumor Size Models Based on Erlotinib Clinical Data in Advanced NSCLCAnna Mishina, Kirill Zhudenkov, Gabriel Helmlinger, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 4, 2025
Assessing Cytochrome P450 Drug Interaction Risk for Dordaviprone Using Physiologically Based Pharmacokinetic ModelingSwati Jaiswal, Nikunjkumar K Patel, Hannah M Jones, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 31, 2025
PBPK Modeling to Predict Clinical Drug-Drug Interaction and Impact of Hepatic Impairment for an ADC With the Payload Auristatin F-HydroxypropylamideNiyanta Kumar, Vaishali Dixit, Howard Burt, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 5, 2025
A Pharmacometrics-Informed Trial Simulation Framework for Optimizing Study Designs for Disease-Modifying Treatments in Rare Neurological DisordersYevgen Ryeznik, Ralf-Dieter Hilgers, Nicole Heussen, et al.
Pageof 153